Dublin, May 14, 2025 (GLOBE NEWSWIRE) -- The "Clinical Diagnostics Automation - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Clinical Diagnostics Automation was valued at US$5.7 Billion in 2024 and is projected to reach US$8.3 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2024-2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Clinical Diagnostics Automation market. 
Computer-Aided Detection (CAD) systems, utilizing advanced algorithms and machine learning, play a crucial role in interpreting medical images and enhancing diagnostic accuracy across various medical fields. These systems assist radiologists by identifying potential abnormalities in images from X-rays, MRIs, endoscopies, and ultrasounds, providing vital diagnostic support. With the integration of sophisticated technologies such as artificial intelligence, CAD systems are becoming increasingly vital in fields like digital pathology, preventive screenings, and emergency diagnostics. The growing demand for these systems is driven by their ability to improve patient outcomes by supporting early detection and accurate diagnosis, particularly in complex areas such as cancer.
Technological advancements in medical imaging technologies such as mammography and MRI, coupled with the rising prevalence of cancer, are major drivers for the CAD market. These improvements lead to more precise and higher-resolution images, allowing CAD software to perform more accurate analyses. Additionally, the shift towards cloud computing in healthcare has enabled the development of scalable and accessible CAD solutions that offer reduced IT costs and enhanced collaboration among healthcare providers. The trend towards multi-modality CAD systems, capable of analyzing images from various diagnostic equipment, further enhances diagnostic accuracy and patient outcomes.
The integration of AI in CAD systems marks a significant evolution in medical imaging, providing tools that learn from vast datasets to recognize complex patterns and anomalies indicative of diseases such as cancer. This AI integration speeds up diagnostics and reduces human error, aligning with the increasing emphasis on preventative healthcare and early diagnosis. Beyond general imaging, CAD systems find specialized applications in detecting conditions such as polyps in colonoscopy and lung nodules in pulmonology. Innovations in CAD are also making headways into digital pathology, with ongoing research expanding its applications beyond immunostaining to include broader diagnostic tasks such as analyzing standard H&E stains, highlighting its potential to significantly impact future medical practices.
Tariff Impact Analysis: Key Insights for 2025
Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.
The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Clinical Diagnostics Automation Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Clinical Diagnostics Automation Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Abaxis Inc., Abbott Diagnostics, Beckman Coulter Inc., Becton Dickinson and Company, bioMerieux SA and more.
- Gain insights into the U.S. market, valued at $1.5 Billion in 2024, and China, forecasted to grow at an impressive 10.6% CAGR to reach $1.9 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
What's Included in This Edition:
- Tariff-adjusted market forecasts by region and segment
- Analysis of cost and supply chain implications by sourcing and trade exposure
- Strategic insights into geographic shifts
Buyers receive a free July 2025 update with:
- Finalized tariff impacts and new trade agreement effects
- Updated projections reflecting global sourcing and cost shifts
- Expanded country-specific coverage across the industry
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 199 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value (USD) in 2024 | $5.7 Billion |
| Forecasted Market Value (USD) by 2030 | $8.3 Billion |
| Compound Annual Growth Rate | 6.5% |
| Regions Covered | Global |
Key Topics Covered:
MARKET OVERVIEW
- Influencer Market Insights
- Tariff Impact on Global Supply Chain Patterns
- Global Economic Update
- Clinical Diagnostics Automation - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- Global Economic Update
MARKET TRENDS & DRIVERS
- Rising Investments in Biotechnology - A Key Growth Driver
- Microplate instrumentation - An Integral Component of Lab Automation Market
- Modular Automation Surges Ahead of TLA in Adoption
- Automation in Immunohistochemistry offers High Throughput Capabilities
- Demand for Automated Hematology Analyzers on Rise
- Automated Multiplexing Technology and its Role in Clinical Diagnostics Automation
- Laboratory Information System - A Key Aspect of Clinical Diagnostics Automation
- Increasing Demand for High-throughput Testing Drives Clinical Diagnostics Automation Market Growth
- Growth in Molecular Diagnostics Strengthens Business Case for Automation
- Integration of AI and Robotics in Diagnostics Automation Throws Spotlight on Innovation
- Rising Investments in Healthcare Infrastructure Expands Market Horizons
- Development of Integrated Diagnostics Platforms Strengthens Market Position
FOCUS ON SELECT PLAYERS:Some of the 54 companies featured in this Clinical Diagnostics Automation market report
- Abaxis Inc.
- Abbott Diagnostics
- Beckman Coulter Inc.
- Becton Dickinson and Company
- bioMerieux SA
- Bio-Rad Laboratories Inc.
- Diagnostica Stago
- Eppendorf AG
- HORIBA ABX SAS
- Hudson Robotics Inc.
- Ortho Clinical Diagnostics Inc.
- PerkinElmer Inc.
- QIAGEN NV
- Siemens Healthineers
- Sysmex America Inc.
- Tecan Group Ltd.
- Thermo Fischer Scientific Inc.
For more information about this report visit https://www.researchandmarkets.com/r/v6x8pf
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
